Japanese drugmaker Takeda is gearing up to launch its tetravalent dengue vaccine, Qdenga, in India. The vaccine will be ...

Dengue fever, caused by a flavivirus named DENV, is a major global health challenge, risking almost half of the world's ...

Takeda, a Japanese pharmaceutical company, plans to launch its dengue vaccine, Qdenga, in India next year in collaboration ...

Takeda plans to launch its dengue vaccine, Qdenga, in India by next year, partnering with Biological E to support the ...

S’gor exco member talks costs and community hygiene as 2024 dengue cases rise past 30,000 SELANGOR has no plans to change its strategy of emphasising prevention measures to combat dengue, even ...